Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
Stukaite-Ruibiene, Egle, Norvilas, Rimvydas, Dirse, Vaidas, Stankeviciene, Sigita, Vaitkeviciene, Goda Elizabeta
Published in Pathology oncology research (12.09.2022)
Published in Pathology oncology research (12.09.2022)
Get full text
Journal Article
An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders
Rascon, Jelena, Rageliene, Lina, Stankeviciene, Sigita, Palionis, Darius, Tamosiunas, Algirdas Edvardas, Valeviciene, Nomeda, Zvirblis, Tadas
Published in European journal of pediatrics (01.09.2014)
Published in European journal of pediatrics (01.09.2014)
Get full text
Journal Article
A RAB27A 5′ untranslated region structural variant associated with late-onset hemophagocytic lympho-histiocytosis and normal pigmentation
Tesi, B, Rascon, J, Chiang, SCC, Burnyte, B, Lofstedt, A, Fasth, A, Heizmann, M, Juozapaite, S, Kiudeliene, R, Kvedaraite, E
Published in Journal of allergy and clinical immunology (01.07.2018)
Published in Journal of allergy and clinical immunology (01.07.2018)
Get full text
Journal Article
Assessment of Risk Factors for Iron Deficiency Anemia in Infants and Young Children: A Case-Control Study
Muleviciene, Audrone, Sestel, Natalija, Stankeviciene, Sigita, Sniukaite-Adner, Daiva, Bartkeviciute, Roma, Rascon, Jelena, Jankauskiene, Augustina
Published in Breastfeeding medicine (01.09.2018)
Published in Breastfeeding medicine (01.09.2018)
Get more information
Journal Article
A RAB27A 5′ untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation
Tesi, Bianca, Rascon, Jelena, Chiang, Samuel C.C., Burnyte, Birute, Löfstedt, Alexandra, Fasth, Anders, Heizmann, Miriam, Juozapaite, Sandra, Kiudeliene, Rosita, Kvedaraite, Egle, Miseviciene, Valdone, Muleviciene, Audrone, Müller, Martha-Lena, Nordenskjöld, Magnus, Matuzeviciene, Reda, Samaitiene, Ruta, Speckmann, Carsten, Stankeviciene, Sigita, Zekas, Vytautas, Voss, Matthias, Ehl, Stephan, Vaiciene-Magistris, Nerija, Henter, Jan-Inge, Meeths, Marie, Bryceson, Yenan T.
Published in Journal of allergy and clinical immunology (01.07.2018)
Published in Journal of allergy and clinical immunology (01.07.2018)
Get full text
Journal Article
A RAB27A 5'UTR structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation
Tesi, Bianca, Rascon, Jelena, Chiang, Samuel C C, Burnyte, Birute, Löfstedt, Alexandra, Fasth, Anders, Heizmann, Miriam, Juozapaite, Sandra, Kiudeliene, Rosita, Kvedaraite, Egle, Miseviciene, Valdone, Muleviciene, Audrone, Müller, Martha-Lena, Nordenskjöld, Magnus, Matuzeviciene, Reda, Samaitiene, Ruta, Speckmann, Carsten, Stankeviciene, Sigita, Zekas, Vytautas, Voss, Matthias, Ehl, Stephan, Vaiciene-Magistris, Nerija, Henter, Jan-Inge, Meeths, Marie, Bryceson, Yenan T
Published in Journal of allergy and clinical immunology (2018)
Published in Journal of allergy and clinical immunology (2018)
Get full text
Journal Article
Liposomal amphotericin B and surgery as successful therapy for pulmonary Lichtheimia corymbifera zygomycosis in a pediatric patient with acute promyelocytic leukemia on antifungal prophylaxis with posaconazole
Kleinotiene, Grazina, Posiunas, Gintas, Raistenskis, Juozas, Zurauskas, Edvardas, Stankeviciene, Sigita, Daugelaviciene, Valentina, Machaczka, Maciej
Published in Medical oncology (Northwood, London, England) (01.03.2013)
Published in Medical oncology (Northwood, London, England) (01.03.2013)
Get full text
Journal Article
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
Stukaite-Ruibiene, Egle, Norvilas, Rimvydas, Dirse, Vaidas, Stankeviciene, Sigita, Vaitkeviciene, Goda Elizabeta
Published in Pathology oncology research : POR (01.01.2022)
Published in Pathology oncology research : POR (01.01.2022)
Get full text
Report